What Diepharmex Laboratories does

Diepharmex Laboratories is a Geneva-headquartered, privately held manufacturer of hygiene and ear care products founded in 1996. Firmographic data describes it as a for-profit company with 11-50 employees. The website (diepharmex.com/en/media) presents a media center that aggregates the corporate communications of an associated European selfcare platform.

The associated source material documents that broader platform's positioning as Europe's largest independent pure-play selfcare business, originally founded as a pharmacists' cooperative outside Paris in 1907. The platform operates across three product categories: Wellbeing Solutions (ongoing vitality), Essential Health (antiseptics, wound care, cold/flu, digestive health), and Personal Care (oral hygiene, women's health, sweat care). Its brand portfolio includes Mag2, Etiaxil, Endwarts, Betadine, CB12, Excilor, Saugella, Sargenor, Armolipid, Valdispert, Froben, Kamillosan, Dagravit, Pouxit, Agiolax, and the recently acquired Nicotinell nicotine replacement therapy line, totaling 25 top brands.

Revenue is generated through unit sales of branded consumer health products distributed via pharmacies, retail chains, and direct-to-consumer channels across Europe. The platform reports €1.1B in net sales, 1,600+ employees representing 30+ nationalities, 5 manufacturing sites, 1 R&D hub, and 10 office sites across Europe. Go-to-market combines organic brand marketing (corporate website in seven languages, LinkedIn, newsroom) with inorganic expansion via acquisitions (Viatris OTC in July 2024, Ferrer Consumer Healthcare in Spain in June 2026) and distribution partnerships (MagnaPharm for Central and Eastern Europe, January 2025).

Name

Diepharmex Laboratories

Legal name

Cooper Consumer Health

Website

https://diepharmex.com

Company type

Private

Founded year

1907

Operating status

Operating

Headcount range

11–50 employees

Short description

Diepharmex Laboratories is a Geneva-based, privately held manufacturer of hygiene and ear care products founded in 1996. The associated source material documents a European selfcare platform operating 25 consumer health brands across pharmacy, retail, and direct-to-consumer channels.

Ownership category

akta.pro rank

Product category

Consumer Health Products

NAICS

Pharmaceutical Preparation Manufacturing (325412), Soap and Cleaning Compound Manufacturing (32561)

SIC

Pharmaceutical Preparations (2834), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Eye, Ear & Nasal Care OTC (Eye Drops, Ear Drops/Wax Removal, Saline Sprays) (CRADAMAG)

akta.pro secondary industry

Eye, Ear & Nasal Care (HLAIADAF)

Keywords

• Hygiene products
• Ear care products
• Consumer health manufacturing
• Personal care brands
• OTC self-care products

Headquarters

HQ city

Geneva

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Consumer Health Products: Cooper Consumer Health generates revenue through the sale of self-care products including wellness solutions, essential health products (antiseptics, wound care, cold and flu, digestive health), and personal care items (oral hygiene, women's health, sweat care). Revenue is generated through sale of physical consumer health products via retail and pharmacy channels across Europe.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Diepharmex Laboratories manufactures and distributes hygiene and ear care products from its base in Geneva, Switzerland. The company markets a portfolio of established personal care and OTC consumer health brands spanning sweat care (Etiaxil), wart treatment (Endwarts), nail and foot care (Excilor), head lice treatment (Pouxit), oral hygiene (CB12), women's health (Saugella), and digestive health (Agiolax), sold through pharmacy, retail, and direct-to-consumer channels across European markets.

Product overview

Cooper Consumer Health is Europe's largest independent pure-play selfcare platform, offering a diversified portfolio of consumer health products across three main categories: Wellbeing Solutions (for ongoing vitality), Essential Health (for short-term health concerns including antiseptics, wound care, cold/flu, and digestive health), and Personal Care (for oral hygiene, women's health, and sweat care). The company markets 25+ top brands including Mag2, Etiaxil, Endwarts, Betadine, CB12, Excilor, Saugella, Sargenor, Armolipid, Valdispert, Froben, Kamillosan, Dagravit, Pouxit, and Agiolax. Following the acquisition of Viatris Inc.'s OTC Business, the portfolio expanded to include Nicotinell nicotine replacement therapy products.

Differentiator

Problem solved

Functional benefit

Brands

• Mag2: Brand product
• Etiaxil
• Endwarts
• Betadine
• CB12
• Excilor
• Saugella
• Sargenor
• Armolipid
• Valdispert
• Froben
• Kamillosan
• Dagravit
• Pouxit
• Agiolax
• Nicotinell

Products and services

• Etiaxil Brand focused on sweat care products for personal hygiene and antiperspirant needs.
• Endwarts Brand providing wart treatment solutions for self-care removal of common warts.
• Excilor Brand offering products for nail and foot health conditions including fungal nail treatment.
• Pouxit Brand offering head lice treatment products for family and pediatric use.
• CB12 Brand providing oral hygiene products for fresh breath and dental health.
• Saugella Brand focused on women's health and intimate care products.
• Agiolax Brand providing natural laxative and digestive health products.
• Betadine Brand offering antiseptic and disinfectant products for wound care.
• Mag2 Brand offering magnesium-based nutritional supplements for health and wellness.
• Sargenor Brand offering arginine-based nutritional supplements.
• Armolipid Brand providing lipid management and cardiovascular health supplements.
• Valdispert Brand offering natural calming and sleep support supplements.
• Froben Brand providing anti-inflammatory pain relief products.
• Kamillosan Brand offering chamomile-based therapeutic products for skin and mucous membrane care.
• Dagravit Brand providing vitamin and nutritional supplement products.
• Nicotinell Brand offering nicotine replacement therapy products for smoking cessation.

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core.

• Ferrer Consumer HealthcarecoreStrategic or Co-development Partner · 1 June 2026Cooper Consumer Health completed the acquisition of Ferrer Consumer Healthcare business in Spain in June 2026. This represents another step-change expansion for Cooper, adding Spanish market presence and portfolio to their European platform.
• MagnaPharmcoreChannel Partner/ Reseller/ Distributor · 1 January 2025Cooper Consumer Health partnered with MagnaPharm for distribution in Central and Eastern Europe. This partnership extends Cooper's distribution reach into CEE markets, strengthening their European footprint. The partnership was announced on January 1, 2025.
• Viatris Inc.coreStrategic or Co-development Partner · 3 July 2024Cooper Consumer Health completed the acquisition of Viatris Inc.'s OTC (Over-The-Counter) business in July 2024. This major acquisition significantly expanded Cooper's OTC portfolio and European market presence. A successful commercial go-live was achieved in Germany in January 2025.

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Otosan: Otosan is an Italian specialty manufacturer focused on ear care and nasal hygiene products — a direct niche peer to Diepharmex with similar product focus, customer base (pharmacies and health retailers), and scale profile.
• Verfora: Verfora is a Swiss OTC consumer health company selling self-care products through Swiss pharmacies. Directly comparable to Diepharmex in geography, OTC category focus, and pharmacy-led distribution.
• Salus Haus: Salus Haus is a German specialty manufacturer of natural health and self-care products sold through pharmacies. Comparable to Diepharmex in European OTC specialty manufacturing, pharmacy-led distribution, and small/mid scale.
• Ems Pharma: Ems Pharma is a Swiss specialty pharmaceutical/OTC manufacturer. Directly comparable to Diepharmex by geography, OTC category exposure, and small specialty manufacturer scale.
• Spitzner Arzneimittel: Spitzner is a German specialty OTC manufacturer focused on herbal and self-care remedies. Comparable in product category (OTC consumer health), European footprint, and small-to-mid specialty manufacturer profile.

Broad incumbents

• Perrigo Company: Perrigo is a major global OTC and consumer self-care manufacturer with broad European presence. Comparable as a much larger incumbent operating in Diepharmex's ear care and personal hygiene end-markets with overlapping product categories.
• Church & Dwight: Church & Dwight is a US-listed consumer health and personal care manufacturer with European OTC presence. Comparable as a broad incumbent competing in hygiene and self-care categories adjacent to Diepharmex's niches.
• Haleon: Haleon is the global OTC consumer health spin-off from GSK, covering oral care, pain relief, and other self-care categories. Comparable as a broad incumbent whose product portfolio overlaps Diepharmex's hygiene and self-care positioning at much greater scale.
• Cooper Consumer Health: Cooper Consumer Health is Europe's largest independent pure-play self-care platform with €1.1B in net sales across OTC, hygiene, and personal care categories. Comparable as a broad incumbent and potential consolidator active in many of Diepharmex's end-markets.
• Bayer Consumer Health: Bayer's Consumer Health division is a global OTC and personal care powerhouse active across dermatology, pain relief, and hygiene. Comparable as a broad incumbent whose portfolio touches multiple of Diepharmex's product categories.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/diepharmex

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diepharmex Laboratories